Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |